Raymond James & Associates’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,550
| Closed | -$33.3K | – | 3844 |
|
|
2023
Q2 | $33.3K | Sell |
20,550
-2,000
| -9% | -$3.24K | ﹤0.01% | 3686 |
|
|
2023
Q1 | $48K | Buy |
22,550
+1,000
| +5% | +$2.13K | ﹤0.01% | 3686 |
|
|
2022
Q4 | $79.7K | Sell |
21,550
-29,611
| -58% | -$110K | ﹤0.01% | 3622 |
|
|
2022
Q3 | $38K | Buy |
+51,161
| New | +$38K | ﹤0.01% | 3684 |
|
|
2021
Q2 | – | Sell |
-40,000
| Closed | -$264K | – | 3968 |
|
|
2021
Q1 | $264K | Buy |
+40,000
| New | +$264K | ﹤0.01% | 3416 |
|